[(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate

C28H35N11O6 — CID 57223169

IUPAC[(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate
SMILESCCN(c1nc(N[C@H](CO)Cc2ccccc2)c2ncn([C@@H]3O[C@H](c4nnn(C)n4)[C@@H](OC=O)[C@H]3OC=O)c2n1)C1CCCN1
InChIInChI=1S/C28H35N11O6/c1-3-38(19-10-7-11-29-19)28-32-24(31-18(13-40)12-17-8-5-4-6-9-17)20-26(33-28)39(14-30-20)27-23(44-16-42)21(43-15-41)22(45-27)25-34-36-37(2)35-25/h4-6,8-9,14-16,18-19,21-23,27,29,40H,3,7,10-13H2,1-2H3,(H,31,32,33)/t18-,19?,21+,22-,23+,27+/m0/s1
InChIKeySLQTULZYLZBITP-KRPWIOJKSA-N
MW621.66 g/mol
LogP0.25
Rot. Bonds14

About [(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate

[(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate (PubChem CID 57223169) has the molecular formula C28H35N11O6 and a molecular weight of 621.66 g/mol. Its IUPAC name is [(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate.

Molecular Properties

Compound Name[(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate
PubChem CID57223169
Molecular FormulaC28H35N11O6
Molecular Weight621.66 g/mol
Exact Mass621.28
IUPAC Name[(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate
SMILESCCN(c1nc(N[C@H](CO)Cc2ccccc2)c2ncn([C@@H]3O[C@H](c4nnn(C)n4)[C@@H](OC=O)[C@H]3OC=O)c2n1)C1CCCN1
InChIInChI=1S/C28H35N11O6/c1-3-38(19-10-7-11-29-19)28-32-24(31-18(13-40)12-17-8-5-4-6-9-17)20-26(33-28)39(14-30-20)27-23(44-16-42)21(43-15-41)22(45-27)25-34-36-37(2)35-25/h4-6,8-9,14-16,18-19,21-23,27,29,40H,3,7,10-13H2,1-2H3,(H,31,32,33)/t18-,19?,21+,22-,23+,27+/m0/s1
InChIKeySLQTULZYLZBITP-KRPWIOJKSA-N
XLogP0.25
TPSA196.56 Ų
H-Bond Donors3
H-Bond Acceptors17
Rotatable Bonds14
Heavy Atoms45
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500621.66
LogP ≤ 50.25
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze [(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate?
The IUPAC name of [(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate (CID 57223169) is [(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate.
What is the SMILES notation for [(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate?
The canonical SMILES for [(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate is CCN(c1nc(N[C@H](CO)Cc2ccccc2)c2ncn([C@@H]3O[C@H](c4nnn(C)n4)[C@@H](OC=O)[C@H]3OC=O)c2n1)C1CCCN1.
What is the InChIKey of [(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate?
The InChIKey is SLQTULZYLZBITP-KRPWIOJKSA-N. The full InChI is InChI=1S/C28H35N11O6/c1-3-38(19-10-7-11-29-19)28-32-24(31-18(13-40)12-17-8-5-4-6-9-17)20-26(33-28)39(14-30-20)27-23(44-16-42)21(43-15-41)22(45-27)25-34-36-37(2)35-25/h4-6,8-9,14-16,18-19,21-23,27,29,40H,3,7,10-13H2,1-2H3,(H,31,32,33)/t18-,19?,21+,22-,23+,27+/m0/s1.
What are the key properties of [(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate?
[(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate has a molecular weight of 621.66 g/mol, XLogP of 0.25, 14 rotatable bonds, 3 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3R,4R,5R)-5-[2-[ethyl(pyrrolidin-2-yl)amino]-6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-4-formyloxy-2-(2-methyltetrazol-5-yl)oxolan-3-yl] formate is sourced from PubChem (CID 57223169), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).